Employer profile
Shepherd Therapeutics
2 certified H-1B filings across 2 fiscal years.
FY2023 filings
1
FY2023 median
$105k
Top role
Computational Scientist
2 filings
Top state
MA
2 filings
Shepherd Therapeutics has filed 2 certified H-1B Labor Condition Applications over FY2020–FY2023. In FY2023, its median certified base salary was $105k ($105k–$105k interquartile range). The most-filed role is Computational Scientist (2 filings).
Year-over-year
How Shepherd Therapeutics hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2023 | 1 | $105k | 0 |
| FY2020 | 1 | $95k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Computational Scientist | 2 | $95k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| MA | 2 | $95k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl I
150%
Lvl II
150%
Frequently asked questions
- Does Shepherd Therapeutics sponsor H-1B visas?
- Yes. Shepherd Therapeutics has filed 2 certified H-1B Labor Condition Applications (LCAs) over FY2020–FY2023. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Shepherd Therapeutics?
- In FY2023, the median certified H-1B base salary at Shepherd Therapeutics was $105k, with a 25th–75th percentile range of $105k–$105k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Shepherd Therapeutics hire H-1B workers for?
- Shepherd Therapeutics's most-filed H-1B role is Computational Scientist (2 filings). Its top worksite state is MA.
- How many H-1B filings did Shepherd Therapeutics submit in FY2023?
- Shepherd Therapeutics had 1 certified H-1B LCA filings in FY2023 — a level reading from the prior fiscal year.